You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ledipasvir

Showing 26 - 50 of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic HCV Infection Trial in China, Korea, Republic of, Taiwan (LDV/SOF)

Completed
Has Results
  • Chronic HCV Infection
  • Beijing, China
  • +44 more
Feb 18, 2020

Hepatitis C Trial in New York (Harvoni (Fixed dose combination ledipasvir/sofosbuvir))

Completed
Has Results
  • Hepatitis C
  • Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
  • New York, New York
    Rockefeller University Hospital
Jul 25, 2019

Hepatitis C Virus Infection Trial in Worldwide (LDV/SOF)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Boston, Massachusetts
  • +20 more
Feb 18, 2020

Healthy Trial in Cairo (Soviredia, Harvoni (first dose), Harvoni (Second dose))

Completed
  • Healthy
  • Cairo, Egypt
    Genuine Research Center GRC
Jul 30, 2019

HEPATITIS C, Virus, Human Immunodeficiency Trial in Aurora (Directly Observed Therapy, Wirelessly Observed Therapy)

Completed
  • HEPATITIS C
  • Virus, Human Immunodeficiency
  • Directly Observed Therapy
  • Wirelessly Observed Therapy
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Mar 4, 2022

Harvoni in Chronic Hepatitis C Virus (HCV) Infection in Korea

Completed
  • Hepatitis C Virus
  • Seongnam-si, Gyeonggido, Korea, Republic of
  • +71 more
Nov 24, 2021

Hepatitis C, Chronic Trial in Belgium (Simeprevir (SMV), Ledipasvir (LDV), Sofosbuvir (SOF))

Completed
Has Results
  • Hepatitis C, Chronic
  • Simeprevir (SMV)
  • +2 more
  • Antwerpen, Belgium
  • +3 more
Mar 27, 2019

Hepatitis C Trial in United States (Sofosbuvir/Ledipasvir x 12 weeks, Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks)

Completed
Has Results
  • Hepatitis C
  • Sofosbuvir/Ledipasvir x 12 weeks
  • Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks
  • Washington, District of Columbia
  • +3 more
Apr 12, 2019

Hepatitis C, Chronic, Hematologic Malignancy Trial in Cairo (Ledipasvir / Sofosbuvir Oral Product)

Unknown status
  • Hepatitis C, Chronic
  • Hematologic Malignancy
  • Ledipasvir / Sofosbuvir Oral Product
  • Cairo, Egypt
    Pediatric Department, Faculty of Medicine, Ain Shams University
Apr 3, 2019

Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

Recruiting
  • Hepatitis C
  • Sofosbuvir 400mg [Sovaldi]
  • Glecaprevir/pibrentasvir (300mg/120mg)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Mar 28, 2022

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

HCV Treatment in a Low-threshold Clinic

Unknown status
  • Hepatitis C
  • Substance Use Disorders
  • Elbasvir / Grazoprevir Oral Tablet
  • Lørenskog, Select A State Or Province, Norway
    AkershusUH
Aug 20, 2019

Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit

Unknown status
  • Antiviral Drug
  • (no location specified)
May 24, 2019

HCV-TARGET- Hepatitis C Therapeutic Registry and Research

Active, not recruiting
  • Hepatitis C
    • Phoenix, Arizona
    • +59 more
    Oct 5, 2022

    The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry

    Recruiting
    • Hepatitis C
    • Direct Acting Antivirals
    • Atlanta, Georgia
      The Taskforce for Global Health
    May 6, 2022

    Chronic Hepatitis c Trial in Chandigarh (Direct Acting Antivirals)

    Unknown status
    • Chronic Hepatitis c
    • Direct Acting Antivirals
    • Chandigarh, India
      Post Graduate Institute of Medical Education and Research
    Jun 13, 2019

    HCV Patients Receiving SOF-based or SOF-free DAAs

    Completed
    • Hepatitis C
    • +2 more
    • Sofosbuvir / Velpatasvir Oral Tablet
    • +5 more
    • Douliu, Taiwan
    • +1 more
    Aug 6, 2019

    Insulin Resistance Trial in Geneva (Ledipasvir 90 mg/Sofosbuvir 400 mg, Ribavirin)

    Completed
    • Insulin Resistance
    • Geneva, GE, Switzerland
      Division of Gastroenterology and hepatology, University Hospital
    Apr 29, 2019

    Strategy for Hepatitis C in Ukraine

    Completed
    • Hepatitis C Virus
    • Sofosbuvir/ledipasvir (SOF/LDV)
    • Kiev, Ukraine
    • +1 more
    Jul 28, 2019

    Chronic Hepatitis C Trial in San Francisco (modified directly observed therapy (mDOT), unobserved dosing, Motivational

    Completed
    • Chronic Hepatitis C
    • modified directly observed therapy (mDOT)
    • +2 more
    • San Francisco, California
      Substance Use Research Unit
    Oct 20, 2020

    Hepatitis C Genotype 4 Trial in Nasr City (Combined therapy LDV and SOF)

    Unknown status
    • Hepatitis C Genotype 4
    • Combined therapy LDV and SOF
    • Nasr City, Cairo, Egypt
      Professor Yassin Abdel Ghaffar Charity Center for Liver Disease
    Nov 14, 2018

    Hepatitis C Trial in Boston (LDV/SOF)

    Completed
    Has Results
    • Hepatitis C
    • Boston, Massachusetts
      (unnamed)
    Oct 19, 2018

    Beta-Thalassemia, Hepatitis C Trial in Tanta (Ledipasvir 90 MG / Sofosbuvir 400 MG [Harvoni])

    Completed
    • Beta-Thalassemia
    • Hepatitis C
    • Ledipasvir 90 MG / Sofosbuvir 400 MG [Harvoni]
    • Tanta, Gharbia Governorate, Egypt
      Pediatric Hematology Unit, Faculty of Medicine, Tanta University
    May 21, 2019

    Hepatitis C Virus Infection Trial in Lutherville (LDV/SOF)

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • Lutherville, Maryland
      (unnamed)
    Oct 19, 2018

    Gaucher Disease, HCV Trial in Mansoura (Ledipasvir/Sofosbuvir)

    Unknown status
    • Gaucher Disease
    • HCV
    • Mansoura, Dakahliya, Egypt
      Mansoura University Children Hospital, Ped Gastroenteroloy and H
    Oct 26, 2018